Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II

This study is examining how a daily low-dose aspirin (enteric-coated) works in people with type 2 diabetes — specifically looking at how the body processes the aspirin and whether it affects blood clotting. The goal is to understand if aspirin dosing strategies need to be adjusted for people with diabetes. **You may be eligible if...** - You are 18 years or older - You have type 2 diabetes (diagnosed by blood sugar tests or treatment with diabetes medications) - You have not taken aspirin regularly in the past 3 months - You are willing to attend all required study visits **You may NOT be eligible if...** - You have a history of heart attack, stroke, or other cardiovascular disease that already requires aspirin - You are allergic to aspirin - You need dialysis or have severe liver problems - You have a stomach ulcer, history of GI bleeding, or H. pylori infection - You take blood thinners, anti-inflammatory drugs (NSAIDs), or steroids regularly - You have active cancer - You are planning major surgery or dental work during the study Talk to your doctor to see if this trial is right for you.